Proceedings of the Tenth International Conference of Drug Regulatory Authorities (ICDRA) - Hong Kong, China, 24 - 27 June 2002
(2002; 166 pages) Ver el documento en el formato PDF
Índice de contenido
Ver el documentoAbbreviations and acronyms used in this report
Abrir esta carpeta y ver su contenidoOpening ceremony
Abrir esta carpeta y ver su contenidoHerbal medicines
Abrir esta carpeta y ver su contenidoKeynote address
Abrir esta carpeta y ver su contenidoSafety of blood-derived products
Abrir esta carpeta y ver su contenidoAntimicrobial resistance - new initiatives
Abrir esta carpeta y ver su contenidoHarmonization I
Cerrar esta carpetaHarmonization II
Ver el documentoRegional harmonization initiatives - the Association of South-East Asian Nations (ASEAN)
Ver el documentoHarmonization in the Americas
Ver el documentoCentralized drug registration system in the Gulf Region
Ver el documentoRecommendations
Abrir esta carpeta y ver su contenidoProtection of trial subjects in clinical trials
Abrir esta carpeta y ver su contenidoRegulating biotechnology products
Abrir esta carpeta y ver su contenidoRegulatory challenges: health sector reform and drug regulatory capacity
Abrir esta carpeta y ver su contenidoAccess to drugs and vaccines I
Abrir esta carpeta y ver su contenidoAccess to drugs and vaccines II
Abrir esta carpeta y ver su contenidoCounterfeit pharmaceutical products
Abrir esta carpeta y ver su contenidoHomoeopathy
Abrir esta carpeta y ver su contenidoSafety monitoring
Abrir esta carpeta y ver su contenidoE-Commerce
Abrir esta carpeta y ver su contenidoCurrent topics
Abrir esta carpeta y ver su contenidoRegulatory challenges of new technologies
Ver el documentoList of participants
Ver el documentoBack cover
 

Recommendations

It was recognized that international harmonization is characterized by a number of initiatives undertaken in different parts of the world. Such initiatives reflect specific local or regional needs and circumstances. Although these activities and their products may be useful examples and supply important technical knowledge, no single initiative can currently be considered a model for international application or implementation.

1. Countries should take into account local factors, priorities, possible implications, and implementation capacity when evaluating harmonization initiatives and guidance materials produced elsewhere.

2. The development of international regulatory requirements and guidelines should be based on demonstrated public-health needs and should not be driven by technological progress alone.

3. WHO should continue to support regional and local harmonization initiatives aimed at strengthening regulatory capacity and achieving public health goals.

4. Progress should be reported back to the ICDRA.

 

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 3 mayo 2013